You haven't searched anything yet.
Working within Fractyl’s Gene Therapy Research Team, the Senior/Principal Scientist will be integral to the discovery and development of AAV-based gene therapies for the treatment and cure of diabetes, obesity, and other metabolic diseases. Successful candidates will be responsible for contributing to Fractyl’s lead and pipeline programs with a primary focus on design, management, execution, analysis, and data reporting of non-GLP and GLP in vivo studies to evaluate delivery, efficacy, safety, and pharmacology of AAV-gene therapy candidates in various animal models. Achieving this goal will also require scientific oversight of assay development being conducted internally and with CROs. The successful candidate will drive programs forward and ensure timely and effective accomplishment of program goals in close collaboration with the Gene Therapy Research team, CROs, and academic collaborators.
The description and requirements outlined above are general; additional requirements may apply.
Full Time
$149k-183k (estimate)
04/28/2024
07/10/2024